[Irritable bowel syndrome as an interdisciplinary clinical challenge. Current views on its pathophysiology, diagnosis and treatment].
Hollerbach
S
S
Medizinische Universitätsklinik, Knappschaftskrankenhaus, Klinikum der Ruhr-Universität Bochum. stephan.hollerbach@ruhr-uni-bochum.de
Elsenbruch
S
S
Enck
P
P
D000328:Adult; D002243:Carbolines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D003937:Diagnosis, Differential; D004032:Diet; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005769:Gastrointestinal Motility; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007422:Intestines / Q000294:innervation / Q000503:physiopathology; D008297:Male; D011613:Psychotherapy; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013997:Time Factors
D002243:Carbolines; D005765:Gastrointestinal Agents; D007211:Indoles; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; C090840:alosetron; C105050:tegaserod